Skip to content

Correlation of ELWI, tissue edema and blood flow in COVID-19 patients treated with extracorporeal membrane oxygenation

Correlation of ELWI, tissue edema and blood flow in COVID-19 patients treated with extracorporeal membrane oxygenation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00026246
Enrollment
150
Registered
2021-09-14
Start date
2021-09-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung failure (ARDS) lung failure (ARDS) ICD-10 Code 80.0

Interventions

Group 1: Retrospective analysis of CT data sets and pathophysiological parameters from our patient data management system of patients treated for respiratory failure due to a SARS-CoV-2 infection with

Sponsors

Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsmedizin Mannheim
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who were treated in our ICU for respiratory failure with or without SARS-CoV-2 infection and extracorporeal membrane oxygenation therapy between the years 2016 and today.

Exclusion criteria

Exclusion criteria: All patients with respiratory failure who did not receive extracorporeal membrane oxygenation therapy.

Design outcomes

Primary

MeasureTime frame
Is there a linear correlation between the EVLWI measured via transpulmonal thermodilution (PICCO) and the actual lung edema measured via CT-scans in patients suffering from respiratory failure due to COVID-19 and receiving extracorporeal membrane oxygenation therapy (ECMO)?

Secondary

MeasureTime frame
How does the extracorporeal membrane oxygenation blood flow correlate with the extravascular lung water index (EVLWI) and the pulmonary oedema determined by computed tomography?

Countries

Germany

Contacts

Public ContactJörg Krebs

Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsmedizin Mannheim

joerg.krebs@umm.de+49 621 383-3233

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026